Nom du produit:6-Acetoxy-4-chloro-7-methoxyquinazoline

IUPAC Name:4-chloro-7-methoxyquinazolin-6-yl acetate

CAS:230955-75-6
Formule moléculaire:C11H9ClN2O3
Pureté:97%
Numéro de catalogue:CM142520
Poids moléculaire:252.65

Unité d'emballage Stock disponible Prix($) Quantité
CM142520-10g in stock ŌŮ
CM142520-25g in stock ǟƚħ
CM142520-100g in stock ƚǸƚ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:230955-75-6
Formule moléculaire:C11H9ClN2O3
Point de fusion:-
Code SMILES:CC(OC1=CC2=C(Cl)N=CN=C2C=C1OC)=O
Densité:
Numéro de catalogue:CM142520
Poids moléculaire:252.65
Point d'ébullition:364.609°C at 760 mmHg
N° Mdl:MFCD08460968
Stockage:Keep in inert atmosphere, store at 2-8°C.

Category Infos

Quinazolines
Quinazolines belong to heterocyclic chemistry, also known as 1,3-naphthalenes. The backbone consists of two six-membered aromatic rings fused to each other, with two nitrogen atoms at positions 1 and 3 on the backbone. The presence of these two nitrogen atoms in quinazoline increases its importance in pharmaceutical and biological reactions. Quinazolines and their derivatives are among the most important heterocyclic compounds due to their diverse chemical reactivity and important range of biological activities.

Column Infos

SE-9
SE-9 is a novel dual-targeting SOS1/EGFR inhibitor that represents a promising treatment strategy for prostate cancer.
Multitarget medications represent an appealing therapy against the disease with multifactorial abnormalities─cancer. Therefore, simultaneously targeting son of sevenless 1 (SOS1) and epidermal growth factor receptor (EGFR), two aberrantly expressed proteins crucial for the oncogenesis and progression of prostate cancer, may achieve active antitumor effects. 

Related Products